
Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
Author(s) -
W.D. Kufel,
A.S. Devanathan,
A.H. Marx,
D.J. Weber,
L.M. Daniels
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/4hhy-7t71
Subject(s) - clostridium difficile , microbiology and biotechnology , medicine , clostridium , infection control , intensive care medicine , biology , bacteria , antibiotics , genetics